Please login to the form below

Not currently logged in
Email:
Password:

Q4 results

This page shows the latest Q4 results news and features for those working in and with pharma, biotech and healthcare.

Bluebird bio leans on pipeline and Zynteglo launch as revenues fall

Bluebird bio leans on pipeline and Zynteglo launch as revenues fall

Bluebird is in partnership with BMS for a BCMA-targeting cell therapy – bb2121 or ide-cel – which recently demonstrated positive top-line results in multiple myeloma. ... Despite making headway in Europe, Zynteglo – also called LentiGlobin – is

Latest news

More from news
Approximately 11 fully matching, plus 27 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics